TERM ID="NYU_TERM_1" STRING="Clinical Excellence" FREQUENCY=1 START=424 END=443 LEMMA="CLINICAL EXCELLENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Eltrombopag" FREQUENCY=3 START=0 END=11 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_3" STRING="Eltrombopag" FREQUENCY=3 START=676 END=687 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_4" STRING="Eltrombopag" FREQUENCY=3 START=1446 END=1457 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_5" STRING="Further analyses" FREQUENCY=1 START=2401 END=2417 LEMMA="FURTHER ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="ICER" FREQUENCY=3 START=2371 END=2375 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="ICER" FREQUENCY=3 START=2433 END=2437 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_8" STRING="ICER" FREQUENCY=3 START=2863 END=2867 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_9" STRING="ITP" FREQUENCY=6 START=87 END=90 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_10" STRING="ITP" FREQUENCY=6 START=321 END=324 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_11" STRING="ITP" FREQUENCY=6 START=503 END=506 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_12" STRING="ITP" FREQUENCY=6 START=1280 END=1283 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_13" STRING="ITP" FREQUENCY=6 START=1430 END=1433 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_14" STRING="ITP" FREQUENCY=6 START=3191 END=3194 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_15" STRING="Idiopathic thrombocytopenic purpura" FREQUENCY=1 START=1393 END=1428 LEMMA="IDIOPATHIC THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_16" STRING="MS" FREQUENCY=2 START=379 END=381 LEMMA="M" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="MS" FREQUENCY=2 START=3116 END=3118 LEMMA="M" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="Median duration" FREQUENCY=1 START=1909 END=1924 LEMMA="MEDIAN DURATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="QALY" FREQUENCY=2 START=2503 END=2507 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="QALY" FREQUENCY=2 START=2561 END=2565 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_21" STRING="UK marketing authorisation" FREQUENCY=1 START=800 END=826 LEMMA="UK MARKETING AUTHORISATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="UK/USA" FREQUENCY=1 START=617 END=623 LEMMA="UK/USA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="adult ITP" FREQUENCY=1 START=853 END=862 LEMMA="ADULT ITP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="antibodies" FREQUENCY=1 START=542 END=552 LEMMA="ANTIBODY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="autoimmune disorder" FREQUENCY=1 START=513 END=532 LEMMA="AUTOIMMUNE DISORDER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="base-case results" FREQUENCY=1 START=2923 END=2940 LEMMA="BASE-CASE RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="bleeding events" FREQUENCY=1 START=2135 END=2150 LEMMA="BLEEDING EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="chronic ITP" FREQUENCY=1 START=3575 END=3586 LEMMA="CHRONIC ITP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="chronic idiopathic" FREQUENCY=2 START=33 END=51 LEMMA="CHRONIC IDIOPATHIC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="chronic idiopathic" FREQUENCY=2 START=267 END=285 LEMMA="CHRONIC IDIOPATHIC" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="clinical effectiveness" FREQUENCY=1 START=173 END=195 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="comparators" FREQUENCY=1 START=3506 END=3517 LEMMA="COMPARATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="confidence interval" FREQUENCY=1 START=1746 END=1765 LEMMA="CONFIDENCE INTERVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="controlled trial" FREQUENCY=1 START=1470 END=1486 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="cost-effectiveness" FREQUENCY=3 START=200 END=218 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_36" STRING="cost-effectiveness" FREQUENCY=3 START=3337 END=3355 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_37" STRING="cost-effectiveness" FREQUENCY=3 START=3443 END=3461 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_38" STRING="cost-effectiveness of eltrombopag" FREQUENCY=2 START=200 END=233 LEMMA="ELTROMBOPAG COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_39" STRING="cost-effectiveness of eltrombopag" FREQUENCY=2 START=3337 END=3370 LEMMA="ELTROMBOPAG COST-EFFECTIVENESS" LEMMA_FREQUENCY=2 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_40" STRING="economic model" FREQUENCY=1 START=2229 END=2243 LEMMA="ECONOMIC MODEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="economic models" FREQUENCY=1 START=1130 END=1145 LEMMA="ECONOMIC MODEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="eltrombopag" FREQUENCY=6 START=222 END=233 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_43" STRING="eltrombopag" FREQUENCY=6 START=2302 END=2313 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_44" STRING="eltrombopag" FREQUENCY=6 START=2986 END=2997 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_45" STRING="eltrombopag" FREQUENCY=6 START=3075 END=3086 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_46" STRING="eltrombopag" FREQUENCY=6 START=3144 END=3155 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_47" STRING="eltrombopag" FREQUENCY=6 START=3359 END=3370 LEMMA="ELTROMBOPAG" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_48" STRING="eltrombopag group" FREQUENCY=1 START=1787 END=1804 LEMMA="ELTROMBOPAG GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="evidence review group" FREQUENCY=1 START=129 END=150 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="follow-up studies" FREQUENCY=1 START=3215 END=3232 LEMMA="FOLLOW-UP STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="high-quality RAISE" FREQUENCY=1 START=1343 END=1361 LEMMA="HIGH-QUALITY RAISE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="incidence rates" FREQUENCY=1 START=594 END=609 LEMMA="INCIDENCE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="incremental cost-effectiveness ratio" FREQUENCY=2 START=2333 END=2369 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_54" STRING="incremental cost-effectiveness ratio" FREQUENCY=2 START=2333 END=2369 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_55" STRING="life-year" FREQUENCY=1 START=2492 END=2501 LEMMA="LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="manufacturer" FREQUENCY=1 START=351 END=364 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="marketing authorisation" FREQUENCY=1 START=3598 END=3621 LEMMA="MARKETING AUTHORISATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="non-randomised non-comparative data" FREQUENCY=1 START=2713 END=2748 LEMMA="NON-RANDOMISED NON-COMPARATIVE DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="non-splenectomised" FREQUENCY=1 START=2567 END=2585 LEMMA="NON-SPLENECTOMISED" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="non-splenectomised patient groups" FREQUENCY=1 START=1059 END=1092 LEMMA="NON-SPLENECTOMISED PATIENT GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="non-splenectomised patients" FREQUENCY=4 START=970 END=997 LEMMA="NON-SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_62" STRING="non-splenectomised patients" FREQUENCY=4 START=1818 END=1845 LEMMA="NON-SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_63" STRING="non-splenectomised patients" FREQUENCY=4 START=2006 END=2033 LEMMA="NON-SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_64" STRING="non-splenectomised patients" FREQUENCY=4 START=3644 END=3671 LEMMA="NON-SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_65" STRING="odds ratio" FREQUENCY=1 START=1726 END=1736 LEMMA="ODDS RATIO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="platelet count" FREQUENCY=1 START=1644 END=1658 LEMMA="PLATELET COUNT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="platelets" FREQUENCY=2 START=572 END=581 LEMMA="PLATELET" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_68" STRING="platelets" FREQUENCY=2 START=716 END=725 LEMMA="PLATELET" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_69" STRING="primary outcome" FREQUENCY=1 START=1623 END=1638 LEMMA="PRIMARY OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="primary outcome of a platelet count" FREQUENCY=1 START=1623 END=1658 LEMMA="PLATELET COUNT PRIMARY OUTCOME" LEMMA_FREQUENCY=1 HEAD_TERM="primary outcome" HEAD_LEMMA="PRIMARY OUTCOME"
TERM ID="NYU_TERM_71" STRING="quality-adjusted life-year" FREQUENCY=1 START=2475 END=2501 LEMMA="QUALITY-ADJUSTED LIFE-YEAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="rescue medication" FREQUENCY=1 START=2095 END=2112 LEMMA="RESCUE MEDICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="second-line treatment" FREQUENCY=1 START=938 END=959 LEMMA="SECOND-LINE TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="second-line treatment post rituximab" FREQUENCY=1 START=3001 END=3037 LEMMA="SECOND-LINE TREATMENT POST RITUXIMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_75" STRING="splenectomised patients" FREQUENCY=3 START=866 END=889 LEMMA="SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_76" STRING="splenectomised patients" FREQUENCY=3 START=1862 END=1885 LEMMA="SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_77" STRING="splenectomised patients" FREQUENCY=3 START=1970 END=1993 LEMMA="SPLENECTOMISED PATIENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_78" STRING="subjects" FREQUENCY=1 START=2172 END=2180 LEMMA="SUBJECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_79" STRING="technology appraisal process" FREQUENCY=1 START=473 END=501 LEMMA="TECHNOLOGY APPRAISAL PROCESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_80" STRING="thrombocytopenic purpura" FREQUENCY=2 START=61 END=85 LEMMA="THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_81" STRING="thrombocytopenic purpura" FREQUENCY=2 START=295 END=319 LEMMA="THROMBOCYTOPENIC PURPURA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_82" STRING="time horizon" FREQUENCY=1 START=2957 END=2969 LEMMA="TIME HORIZON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_83" STRING="treatment model" FREQUENCY=1 START=2671 END=2686 LEMMA="TREATMENT MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_84" STRING="treatment period" FREQUENCY=1 START=1708 END=1724 LEMMA="TREATMENT PERIOD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_85" STRING="treatment sequences" FREQUENCY=1 START=2828 END=2847 LEMMA="TREATMENT SEQUENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_86" STRING="watch-and-rescue" FREQUENCY=1 START=2212 END=2228 LEMMA="WATCH-AND-RESCUE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_87" STRING="watch-and-rescue economic model" FREQUENCY=1 START=2212 END=2243 LEMMA="ECONOMIC MODEL WATCH-AND-RESCUE" LEMMA_FREQUENCY=1 HEAD_TERM="economic model" HEAD_LEMMA="ECONOMIC MODEL"
TERM ID="NYU_TERM_88" STRING="watch-and-rescue treatment scenario" FREQUENCY=1 START=1172 END=1207 LEMMA="WATCH-AND-RESCUE TREATMENT SCENARIO" LEMMA_FREQUENCY=1
